肝转移瘤的定量生物标志物:MRI扩散加权成像异质性指数与混合PET/MR中氟-18-氟脱氧葡萄糖标准化摄取值的比较
研究纳入24例肿瘤患者共39个肝转移瘤,在PET/MRI系统上比较ADC异质性指数(ADCcv)与常规MRI指标区分肝转移瘤与正常表现肝组织的能力,并分析其与18F-FDG PET SUV的相关性;ADCcv与SUVpeak呈良好相关(r=0.712),ROC分析中SUV、ADCcv、ADCmin、ADCmean的AUC分别为0.989、0.900、0.742、0.623。
要点
- ADCcv与SUVpeak呈良好相关(r=0.712),优于ADCmin(r=-0.536)和ADCmean(r=-0.273)。
- ADCcv区分肝转移瘤与正常表现肝组织的AUC为0.900,低于SUV的0.989,高于ADCmin的0.742和ADCmean的0.623。
- ADCcv和ADCmin在肝转移瘤与正常表现肝组织间差异有统计学意义(p<0.0001和p=0.001)。
核心结论
- ADCcv指数是肝转移瘤的潜在生物标志物,与18F-FDG PET SUVpeak的相关性优于常规MRI指标,可能用于定量区分肝转移瘤与正常表现肝组织。
研究设计与样本
- 研究纳入24例肿瘤患者(13例女性、11例男性,平均年龄56±13岁)共39个肝转移瘤,转移来源异质,在PET/MRI系统上评估。
- 腹部序列包括Dixon和扩散加权成像(DWI)方案并同步行PET采集。
- 组织异质性用ADC的变异系数(CV)计算,并在肝转移瘤与同一肝脏相邻部位相同体积的正常表现肝组织之间比较。
- 评估多种ADC指标与PET SUV在区分肝转移瘤与正常表现肝组织中的相关性。
诊断标准与关键数值
- ADCcv与SUVpeak呈良好相关(r=0.712)。
- ADCmin与SUVpeak呈中度负相关(r=-0.536),ADCmean与SUVpeak呈弱负相关(r=-0.273)。
- ADCcv用于区分肝转移瘤与正常表现肝组织时p<0.0001,ADCmin为p=0.001。
- ROC分析区分肝转移瘤与正常表现肝组织的AUC:SUV为0.989、ADCcv为0.900、ADCmin为0.742、ADCmean为0.623。
临床应用与阅片要点
- 原文结论认为ADCcv指数是肝转移瘤的潜在生物标志物,可能用于定量区分肝转移瘤与正常表现肝组织。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
AIM: To investigate the ability of apparent diffusion coefficient (ADC) heterogeneity index to discriminate liver metastases (LM) from normal-appearing liver (NAL) tissue as compared to common magnetic resonance imaging (MRI) metrics, and to investigate its correlation with 2-[18F]-fluoro-2-deoxy-d-glucose (18F-FDG) positron-emission tomography (PET) standardised uptake value (SUV).
MATERIALS AND METHODS: Thirty-nine liver metastases in 24 oncology patients (13 women, 11 men; mean age 56±13 years) with proven LM from heterogeneous sources were evaluated on a PET/MRI system. Abdominal sequences included Dixon and diffusion-weighted imaging (DWI) protocols with simultaneous PET. Tissue heterogeneity was calculated using the coefficient of variance (CV) of the ADC, and compared in LM and in NAL tissue of the same volume in an adjacent portion of the liver. The correlations between various ADC measures and PET SUV in distinguishing LM from NAL were evaluated.
RESULTS: A good correlation was found between ADCcv and SUVpeak (r=0.712). Moderate inverse correlation was found between ADCmin and SUVpeak (r=-0.536), and a weak inverse correlation between ADCmean and SUVpeak (r=-0.273). There was a significant difference between LM and NAL when ADCcv (p<0.0001) and ADCmin (p=0.001) were used. Receiver operating characteristic (ROC) analysis of SUV, ADCcv, ADCmin, and ADCmean produced an AUC of 0.989, 0.900, 0.742, and 0.623 respectively.
CONCLUSIONS: The ADCcv index is a potential biomarker of LM with better correlation to 18F-FDG PET SUVpeak than conventional MRI metrics, and may serve to quantitatively discriminate between LM and NAL.
引用
- Stein D, Goldberg N, Domachevsky L, et al. Quantitative biomarkers for liver metastases: comparison of MRI diffusion-weighted imaging heterogeneity index and fluorine-18-fluoro-deoxyglucose standardised uptake value in hybrid PET/MR. Clin Radiol. 2018. PMID: 29859634. doi:10.1016/j.crad.2018.04.012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。